Newswire
ภาษาไทย
English-
CISION PR Newswire - Z Grills Announces Unprecedented "Buy 1, Get 10 Gr...
ONTARIO, Calif., June 1, 2024 /PRNewswire/ -- Mark your calendars, grill masters! Z Grills, the innovator in premium wood pellet grills, is sizzling up summer with a groundbreaking promotion that's su... -
CISION PR Newswire - ICECO Launches APL35 on Indiegogo - The World's Li...
BREA, Calif., June 1, 2024 /PRNewswire/ -- ICECO, a leading expert in portable refrigeration solutions, announces the launch of the world's lightest dual-zone aluminum portable freezer, the APL35, on ... -
CISION PR Newswire - Tag along with Jason in Zhengzhou: Experiencing Ku...
BEIJING, May 30, 2024 /PRNewswire/ -- This is a report from China.org.cn about the Shaolin Temple:  Guided by a friend who trains at the Shaolin Temple, Jason Castleton visit... -
CISION PR Newswire - Immunocan Launches Innovative Alpaca-derived Nanob...
BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse g... -
CISION PR Newswire - TiumBio Presents Phase 1b Interim Results for TU22...
Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients with advanced solid tumors A 4... -
CISION PR Newswire - Ivonescimab in Combination with Chemotherapy Appro...
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of Patients Previously Receiving... -
CISION PR Newswire - Duke-NUS' largest graduating cohort celebrates div...
The largest graduating class in Duke-NUS' history saw 90 graduates, including the first-ever Master of International Translational Medicine cohort, receive their degrees Collectively, this cohort... -
CISION PR Newswire - Innovent Announces Taletrectinib（ROS1 Inhibitor）Up...
SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercialize... -
CISION PR Newswire - Jacobio Pharma Presents SHP2 Plus KRAS G12C Data a...
BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibi... -
CISION PR Newswire - CStone Announces European Medicine Agency CHMP Rec...
EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalima...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.